Bright Minds Biosciences Inc (DRUG)

Feb 24, 2025

Bright Minds Biosciences to Participate at Three Healthcare Conferences in March - The Manila Times

Feb 24, 2025

Feb 24, 2025

Can This CNS Drug Developer's Triple Conference Tour Spark Investor Interest? - StockTitan

Feb 24, 2025

Feb 23, 2025

How the (DRUG) price action is used to our Advantage - Stock Traders Daily

Feb 23, 2025

Feb 22, 2025

HC Wainwright Issues Negative Estimate for DRUG Earnings - Defense World

Feb 22, 2025

Feb 21, 2025

H.C. Wainwright maintains $85 target on Bright Minds stock By Investing.com - Investing.com Nigeria

Feb 21, 2025

Feb 20, 2025

H.C. Wainwright maintains $85 target on Bright Minds stock - Investing.com India

Feb 20, 2025

Feb 20, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Given “Buy” Rating at HC Wainwright - Defense World

Feb 20, 2025

Feb 19, 2025

Bright Minds Biosciences’ BMB-101: A Promising Contender in Serotonergic Epilepsy Treatment with Strong Market Potential - TipRanks

Feb 19, 2025

Feb 14, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Announces Earnings Results, Beats Estimates By $0.24 EPS - MarketBeat

Feb 14, 2025

Feb 14, 2025

Bright Minds Biosciences Dramatic Surge Highlights the High-Stakes Nature of Biotech Investments - HPBL

Feb 14, 2025

Feb 14, 2025

BriaCell Therapeutics: A Biotech Stock on the Brink of a Turnaround? - HPBL

Feb 14, 2025

Feb 14, 2025

Biotechs on the Brink: 2 Stocks With Huge Potential - Benzinga

Feb 14, 2025

Feb 14, 2025

Bright Minds Biosciences Shows Financial Improvement in Latest Report - TipRanks

Feb 14, 2025

Feb 12, 2025

When (DRUG) Moves Investors should Listen - Stock Traders Daily

Feb 12, 2025

Feb 05, 2025

SEC Form F-3 filed by Bright Minds Biosciences Inc. - Quantisnow

Feb 05, 2025

Feb 04, 2025

More Money In The Bank For Bright Minds Biosciences Insiders Who Divested CA$16m - Simply Wall St

Feb 04, 2025

Feb 04, 2025

How To Buy Bright Minds Biosciences Inc. Stock Online in February 2025 - Traders Union

Feb 04, 2025

Jan 31, 2025

Long Term Trading Analysis for (DRUG) - Stock Traders Daily

Jan 31, 2025

Jan 26, 2025

Bright Minds Biosciences: Looking To Change Scope Of Epilepsy Disorder Treatments With BMB-101 - Seeking Alpha

Jan 26, 2025

Jan 26, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Research Coverage Started at Piper Sandler - Defense World

Jan 26, 2025

Jan 24, 2025

Piper Sandler sets $93 target for Bright Minds Biosciences stock - MSN

Jan 24, 2025

Jan 24, 2025

Piper Sandler Initiates Coverage of Bright Minds Biosciences (DRUG) with Overweight Recommendation - MSN

Jan 24, 2025

Jan 24, 2025

Piper Sandler sets $93 target for Bright Minds Biosciences stock By Investing.com - Investing.com South Africa

Jan 24, 2025

Jan 24, 2025

Cantor Fitzgerald Predicts DRUG FY2025 Earnings - Defense World

Jan 24, 2025

Jan 23, 2025

Cantor Fitzgerald Comments on DRUG FY2025 Earnings - MarketBeat

Jan 23, 2025

Jan 23, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Now Covered by Analysts at Piper Sandler - MarketBeat

Jan 23, 2025

Jan 23, 2025

This Prudential Financial Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Jan 23, 2025

Jan 22, 2025

5-HT2 Agonist Clinical Trial Pipeline Appears Robust With - GlobeNewswire

Jan 22, 2025

Jan 21, 2025

Learn to Evaluate (DRUG) using the Charts - Stock Traders Daily

Jan 21, 2025

Jan 16, 2025

Bright Minds Biosciences Appoints New Chief Medical Officer to Advance CNS Therapeutics - MSN

Jan 16, 2025

Jan 14, 2025

Top 4 Canadian Biotech Stocks (Updated January 2025) - Investing News Network

Jan 14, 2025

Jan 14, 2025

Head-To-Head Analysis: Bright Minds Biosciences (NASDAQ:DRUG) versus Enlivex Therapeutics (NASDAQ:ENLV) - Defense World

Jan 14, 2025

Jan 12, 2025

Cantor Fitzgerald Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Jan 12, 2025

Jan 12, 2025

HC Wainwright Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Jan 12, 2025

Jan 10, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Coverage Initiated by Analysts at Cantor Fitzgerald - MarketBeat

Jan 10, 2025

Jan 10, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at HC Wainwright - MarketBeat

Jan 10, 2025

Jan 08, 2025

Top 5 Small-cap Biotech Stocks (Updated January 2025) - Investing News Network

Jan 08, 2025

Jan 07, 2025

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer - The Manila Times

Jan 07, 2025

Jan 07, 2025

Bright Minds Biosciences Appoints Stephen Collins, M.D., Ph.D., as Chief Medical Officer - citybiz

Jan 07, 2025

Jan 01, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Releases Earnings Results - MarketBeat

Jan 01, 2025

Dec 31, 2024

Bright Minds Biosciences (DRUG) Finishes the Year with Phenomenal Share Price Increase - Nasdaq

Dec 31, 2024

Dec 31, 2024

(DRUG) Long Term Investment Analysis - Stock Traders Daily

Dec 31, 2024

Dec 20, 2024

Best-Performing Small-Cap Stocks of 2024 - Investing.com

Dec 20, 2024

Dec 19, 2024

Bright Minds Biosciences (NASDAQ:DRUG) Shares Down 4.3% – Time to Sell? - Defense World

Dec 19, 2024

Dec 19, 2024

Bright Minds Biosciences (NASDAQ:DRUG) Shares Down 4.3%Time to Sell? - MarketBeat

Dec 19, 2024

Dec 10, 2024

(DRUG) Investment Analysis - Stock Traders Daily

Dec 10, 2024

Dec 08, 2024

Retail investors among Bright Minds Biosciences Inc.'s (CSE:DRUG) largest stockholders and were hit after last week's 10% price drop - Simply Wall St

Dec 08, 2024

Nov 28, 2024

Baird Initiates Coverage of Bright Minds Biosciences (DRUG) with Outperform Recommendation - MSN

Nov 28, 2024

Nov 27, 2024

Bright Minds Buosciences Surges 5,900% Last Week. Attention Turning To Cybin ($CYBN) Rallying 23% On Upcoming... - Daily Scanner

Nov 27, 2024

Nov 27, 2024

Bright Minds Biosciences (NASDAQ:DRUG) Raised to "Strong-Buy" at Baird R W - MarketBeat

Nov 27, 2024